An open label non comparative phase II trial of ZD1839 (Iressa) in combination with docetaxel (TAXOTERE) in patients with advanced or metastatic non small cell lung cancer failing or unsuitable for platinum based chemotherapy
Study identifier:1839IL/0105
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
An open label non comparative phase II trial of ZD1839 (Iressa) in combination with docetaxel (TAXOTERE) in patients with advanced or metastatic non small cell lung cancer failing or unsuitable for platinum based chemotherapy
Medical condition
lung cancer
Phase
Phase 2
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Jun 2002
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
